During the past decade, Owensboro Dermatology Associates conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Owensboro Dermatology Associates" are "Psoriasis Vulgaris" (3 trials), "Dermatitis, Atopic" (2 trials), "Plaque Psoriasis" (2 trials), "Dermatitis" (1 trials) and "Eczema" (1 trials). Many other conditions were trialed in "Owensboro Dermatology Associates" in a lesser frequency.

Most popular intervention types in "Owensboro Dermatology Associates" are "Drug" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "LEO 90100" (2 trials), "Abrocitinib 100 mg" (1 trials), "Abrocitinib 200 mg" (1 trials) and "Betamethasone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Owensboro Dermatology Associates" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Owensboro Dermatology Associates". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Owensboro Dermatology Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Owensboro Dermatology Associates, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".